Elosulfase alfa

Vimizim 1MG/ML Concentrado Para Solucion Para Perfusion

5 mg concentrado para solución para perfusiónSpainMarketedAuthorised 22 Mar 2015

In other countries

The same active substances on other registers, the same brand first.

VimizimCanada · 1 MG / ML · Solution · Biomarin International LimitedSame brand
VimizimEuropean Union · BioMarin International LimitedSame brand
VimizimCroatiaSame brand
VimizimItaly · Concentrato per soluzione per infusione · Biomarin International LimitedSame brand
Vimizim 1 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · BioMarin International LimitedSame brand
VIMIZIM 1 mg/mlRomania · 1mg/ml · conc. pt. sol. perf. · Biomarin International LimitedSame brand
VIMIZIM 1mg/mlRomania · 1mg/ml · conc. pt. sol. perf. · Biomarin Europe LimitedSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Elosulfase alfa

Vimizim 1MG/ML Concentrado Para Solucion Para Perfusion

5 mg concentrado para solución para perfusiónSpainMarketedAuthorised 22 Mar 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vimizim®Serbia · 1mg/mL · koncentrat za rastvor za infuziju · Evropa Lek Pharma D.O.O. Beograd

VimizimUnited States · 5MG/5ML · injectable · Biomarin Pharm

Packs

Pack	Code	Status
VIMIZIM 1MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 X 5 ML VIAL	705834

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Elosulfase alfa
Strength: 5 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 22 Mar 2015
Registration: 114914001
Marketing authorisation holder: Biomarin International Limited
Procedure: EU centralised
Supply: Uso Hospitalario